Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:phenylephrine
|
| gptkbp:brand |
gptkb:phenylephrine
|
| gptkbp:containsPseudoephedrine |
false
|
| gptkbp:contraindication |
gptkb:diabetes
heart disease thyroid disease high blood pressure enlarged prostate |
| gptkbp:excludes |
gptkb:pseudoephedrine
|
| gptkbp:FDAApproved |
true
|
| gptkbp:form |
gptkb:tablet
gptkb:water |
| https://www.w3.org/2000/01/rdf-schema#label |
Sudafed PE
|
| gptkbp:legalStatus |
gptkb:OTC
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:notEffectiveAgainst |
sinus pressure (per FDA advisory)
|
| gptkbp:OTC |
true
|
| gptkbp:relatedTo |
gptkb:Sudafed
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
nervousness insomnia |
| gptkbp:usedFor |
nasal congestion
|
| gptkbp:bfsParent |
gptkb:phenylephrine
gptkb:Sudafed |
| gptkbp:bfsLayer |
7
|